Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Venous Access Devices Market size was valued at USD 8.58 billion in 2024 and is expected to reach USD 15.21 billion by 2037, expanding at around 4.5% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of venous access devices is assessed at USD 8.89 billion.
Chronic diseases such as diabetes, heart disease, and kidney failure are at great heights worldwide. Therefore, these health conditions often demand for frequent blood draws, medication administration, and dialysis that necessitate the utilization of venous access devices. As per reports worldwide, around one in three of all adults suffer from some or the other chronic conditions. Around 6 in 10 adults suffer from chronic disease, and 4 in 10 adults at a time suffer from two or more such diseases in the US.
In addition, the integration of infusion pumps is minimal, which increases the acceptance rate, thus anticipating the growth of the venous access devices market. Moreover, the market growth over the forecast period has been further enhanced by the presence of various gauge sizes for venacular devices. The change in size is beneficial for the purpose of serving a variety of purposes, thus enhancing medication accuracy and thereby increasing safety.
Venous Access Devices Sector: Growth Drivers and Challenges
Growth Drivers
- Growing Technological Development to Drive Veterinary Home Diagnostic Sales - The growth of the vascular boot market is expected to be stimulated by various technological developments taking place in the manufacture of infusion pumps and catheters. As a primary treatment option for diabetic patients and chronic disease, demand in the market has been attributed to this. In addition, the integration of these pumps is minimal thus increasing their acceptance and thereby anticipating an increase in demand.
- Multiple Clinical Trials - The venous access devices market is expected to be positively affected by several clinical trials carried out using the available technologies. Because many vascular access devices perform similar functions and differ only slightly from one another, clinical data confirming the safety and cost-effectiveness of some products will have a significant impact on device purchase decisions.
Challenges
- High in Cost – The cost of venous access devices such as central venous catheters and peripheral intravenous catheters can be huge. This can pose burden for patients and healthcare providers.
- Strict Regulations to Hinder the Market Expansion in the Upcoming Period
- High Infection Rates is expected to Hamper the market growth in the forecast period.
Venous Access Devices Market: Key Insights
| Report Attribute | Details |
|---|---|
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
4.5% |
|
Base Year Market Size (2024) |
USD 8.58 billion |
|
Forecast Year Market Size (2037) |
USD 15.21 billion |
|
Regional Scope |
|
Venous Access Devices Segmentation
Device Type (Ablation Device, Surgical Products, Catheter, Venous Closure System)
In terms of device type, the catheter segment is set to hold the largest market share of 40% during the forecast period. With a preference for central catheters, a large proportion of total demand is generated. Direct administration of nutrition and medication directly to the blood vessels is more efficient with centrally placed catheters. To allow patients to remain active and receive intravenous medicinal products at home, central venous catheters are less likely to break off from the vein. In addition, it is capable of providing more blood volume to patients who are severely injured.
End Use (Hospital, Retail Pharmacies, Mail Order Pharmacies, E-commerce)
Based on application, the hospital segment is set to hold the largest market share of 40% by the end of 2037. The presence of qualified and trained staff at dialysis centers and hospitals allows for the best possible care, as well as improved access to blood vessels. A number of reasons, including a growing emphasis by companies on the development of their own cardiovascular access facilities, are anticipated to contribute to this category.
Our in-depth analysis of the global market includes the following segments:
|
Device Type |
|
|
Treatment Type |
|
|
End Use |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Venous Access Devices Industry-Regional Synopsis
North American Market Forecasts
North America industry is likely to account for largest revenue share of 35% by 2037. The USA and Canada are projected to have the largest shares, thus dominating the market. This can be accounted on the back of growing cases of chronic diseases including health concerns such as diabetes, kidney failure, and multiple sclerosis owing to this the regional market is anticipated to register substantial growth. In particular, the Abre vein self-expanding device was innovated and authorized by the Food and Drug Administration in 2020 in the United States
European Market Statistics
The market in the Europe region is set to grow notably by the end of the forecast period. A major increase in the production of generic drugs by various drug companies is expected to meet the need for delivery technology. This has resulted in a large product pipeline and higher returns for existing products, which is an important factor behind the sector's growth. According to press reports, catheters are soft tubes inserted into the largest vein near the heart of the patient.
Companies Dominating the Venous Access Devices Landscape
- Angio Dynamics
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Smiths Medical
- Cook Group Incorporated
- Abbott Laboratories
- Baxter International
- C R Bard
- Reinventing Venous Access
- Becton Dickinson and Company
- Boston Scientific Corporation
- Teleflex Incorporated.
Recent Developments
- AngioDanymics has announced a new collaboration with Minimax Medical to distribute its product range internationally.
- BD has also acquired TVA Medical, a manufacturer of vascular access devices for hemodialysis patients suffering from kidney disease.
- Report ID: 5991
- Published Date: Nov 27, 2024
- Report Format: PDF, PPT
- Get detailed insights on specific segments/region
- Inquire about report customization for your industry
- Learn about our special pricing for startups
- Request a demo of the report’s key findings
- Understand the report’s forecasting methodology
- Inquire about post-purchase support and updates
- Ask About Company-Level Intelligence Additions
Have specific data needs or budget constraints?
Inquiry Before BuyingFrequently Asked Questions (FAQ)
Venous Access Devices Market Report Scope
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Connect with our Expert
